[Seoul Economic TV, 2024.09.02]
Myrrhzone Molyac Institute Publishes Research Findings in SCI-Indexed Global Journal
Myrrhzone Molyac Institute (Biorootics Co., Ltd.), a specialized firm in myrrh fermentation research, announced on the 2nd that its research findings have been published in Applied Sciences, a prestigious SCI-indexed global academic journal.
According to the research paper, antiviral testing of myrrh extracts demonstrated an 81.2% reduction in the influenza virus. Myrrh (Kareube) is a natural resin harvested by incising the bark of Commiphora myrrha, a plant in the Burseraceae family native to Africa and the Arabian Peninsula. It is also known as "myrrh" and appears as pale yellow or dark brown granules of various sizes.
The institute explained that based on these findings, it has developed and begun distributing 'Kareube,' an antimicrobial patented fertilizer that combines fermented myrrh complex extract with soil microorganisms.
Dr. Jin-woo Kim, Director of Myrrhzone Molyac Institute and the developer of the Kareube microbial fertilizer, explained, "Our research identified key polyphenols in myrrh, such as tannic acid, rutin, and quercetin. We also found representative terpenoids, including furanoeudesma-1,3-diene and curzerene."
Dr. Kim added, "The study confirmed that quercetin and rutin are effective anti-inflammatory agents, while furanoeudesma and curzerene are effective in virus reduction. Specifically, the antiviral tests showed an 81.2% decrease in the influenza virus when treated with myrrh extract."
Myrrhzone Molyac Institute previously developed MHS-90, a fermented myrrh complex extract, and obtained a patent (No. 10-1710673) for its application in fertilizers. Leveraging this technology, the company continues to supply Kareube, the antimicrobial patented fertilizer combining fermented myrrh complex and soil microbes, to agricultural farms.
View News
[Seoul Economic TV, 2024.09.02]
Myrrhzone Molyac Institute Publishes Research Findings in SCI-Indexed Global Journal
Myrrhzone Molyac Institute (Biorootics Co., Ltd.), a specialized firm in myrrh fermentation research, announced on the 2nd that its research findings have been published in Applied Sciences, a prestigious SCI-indexed global academic journal.
According to the research paper, antiviral testing of myrrh extracts demonstrated an 81.2% reduction in the influenza virus. Myrrh (Kareube) is a natural resin harvested by incising the bark of Commiphora myrrha, a plant in the Burseraceae family native to Africa and the Arabian Peninsula. It is also known as "myrrh" and appears as pale yellow or dark brown granules of various sizes.
The institute explained that based on these findings, it has developed and begun distributing 'Kareube,' an antimicrobial patented fertilizer that combines fermented myrrh complex extract with soil microorganisms.
Dr. Jin-woo Kim, Director of Myrrhzone Molyac Institute and the developer of the Kareube microbial fertilizer, explained, "Our research identified key polyphenols in myrrh, such as tannic acid, rutin, and quercetin. We also found representative terpenoids, including furanoeudesma-1,3-diene and curzerene."
Dr. Kim added, "The study confirmed that quercetin and rutin are effective anti-inflammatory agents, while furanoeudesma and curzerene are effective in virus reduction. Specifically, the antiviral tests showed an 81.2% decrease in the influenza virus when treated with myrrh extract."
Myrrhzone Molyac Institute previously developed MHS-90, a fermented myrrh complex extract, and obtained a patent (No. 10-1710673) for its application in fertilizers. Leveraging this technology, the company continues to supply Kareube, the antimicrobial patented fertilizer combining fermented myrrh complex and soil microbes, to agricultural farms.
View News